We are live on ! Find out more
MAP

Moody Aldrich Partners Portfolio holdings

AUM $557M
1-Year Est. Return 122.79%
This Fund
S&P 500
This Quarter Est. Return
+8.49%
1 Year Est. Return
+122.79%
3 Year Est. Return
+335.86%
5 Year Est. Return
+437.05%
10 Year Est. Return
+2,951.39%
AUM
$712M
AUM Growth
+$18.4M
Cap. Flow
-$17.3M
Cap. Flow %
-2.43%
Top 10 Hldgs %
19.69%
Holding
205
New
25
Increased
23
Reduced
98
Closed
34

Top Buys

Rank Stock Value
1
PUBM icon
PubMatic
PUBM
+$14.6M
2
OLLI icon
Ollie's Bargain Outlet
OLLI
+$9.92M
3
LHCG
LHC Group LLC
LHCG
+$7.9M
4
BAND
Bandwidth Inc
BAND
+$7.37M
5
LESL icon
Leslie's
LESL
+$6.89M

Top Sells

Rank Stock Value
1
SF
Stifel
SF
+$19.7M
2
LPX icon
Louisiana-Pacific
LPX
+$13.7M
3
NTRA icon
Natera
NTRA
+$11M
4
QTS
QTS REALTY TRUST, INC.
QTS
+$9.55M
5
SITE icon
SiteOne Landscape Supply
SITE
+$8.2M

Sector Composition

Rank Sector Weight
1 Financials 21%
2 Technology 19.88%
3 Industrials 16.9%
4 Consumer Discretionary 12.02%
5 Healthcare 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NEO icon
76
NeoGenomics
NEO
$2.13B
$4.12M 0.58%
91,247
-1,161
-1% -$51.4K
PGTI
77
DELISTED
PGT, Inc.
PGTI
$4.03M 0.57%
+173,607
New +$4.3M
SPWR
78
DELISTED
SunPower Corporation Common Stock
SPWR
$3.91M 0.55%
133,696
-1,672
-1% -$43.1K
SYNA icon
79
Synaptics
SYNA
$4.15B
$3.71M 0.52%
23,852
-7,526
-24% -$1.02M
DRNA
80
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$3.59M 0.5%
96,237
-1,219
-1% -$37.4K
BEAM icon
81
Beam Therapeutics
BEAM
$2.84B
$3.17M 0.45%
+24,616
New +$1.96M
QLYS icon
82
Qualys
QLYS
$6.35B
$3.15M 0.44%
31,321
-423
-1% -$43.1K
VIVO
83
DELISTED
Meridian Bioscience Inc
VIVO
$3.04M 0.43%
137,075
-1,769
-1% -$37.5K
SJI
84
DELISTED
South Jersey Industries, Inc.
SJI
$3M 0.42%
115,539
-1,471
-1% -$37.9K
AXSM icon
85
Axsome Therapeutics
AXSM
$10.9B
$2.97M 0.42%
43,980
-585
-1% -$35.1K
ESNT icon
86
Essent Group
ESNT
$6.33B
$2.92M 0.41%
65,040
-66,103
-50% -$3.21M
IGMS
87
DELISTED
IGM Biosciences
IGMS
$2.91M 0.41%
35,012
-422
-1% -$31.3K
TGTX icon
88
TG Therapeutics
TGTX
$7.62B
$2.89M 0.41%
74,599
-909
-1% -$35.7K
HQY icon
89
HealthEquity
HQY
$8.75B
$2.88M 0.4%
35,717
-36,321
-50% -$2.77M
AB icon
90
AllianceBernstein
AB
$3.47B
$2.62M 0.37%
56,217
– –
WFC icon
91
Wells Fargo
WFC
$264B
$2.45M 0.34%
+54,182
New +$2.42M
SYF icon
92
Synchrony
SYF
$25.6B
$2.45M 0.34%
50,551
– –
BCYC
93
Bicycle Therapeutics
BCYC
$292M
$2.22M 0.31%
73,108
-952
-1% -$28.8K
TAP icon
94
Molson Coors Class B
TAP
$8.1B
$2.05M 0.29%
38,203
– –
TCRR
95
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$2.04M 0.29%
124,062
-1,578
-1% -$31.9K
JHG
96
DELISTED
Janus Henderson
JHG
$2.02M 0.28%
51,949
– –
RS icon
97
Reliance Steel & Aluminium
RS
$21.6B
$1.92M 0.27%
12,709
– –
XRX icon
98
Xerox
XRX
$425M
$1.88M 0.26%
80,005
– –
PRI icon
99
Primerica
PRI
$10B
$1.82M 0.26%
11,883
– –
FHI icon
100
Federated Hermes
FHI
$4.72B
$1.76M 0.25%
51,937
+15,239
+42% +$485K
2 3
4
5 6

Similar funds

CAM
Cander Asset Management New York $557M AUM
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return
CFP
Curran Financial Partners Daniel Island, South Carolina $559M AUM 13.69% 1-Year Est. Return
TC
Truvestments Capital Sarasota, Florida $554M AUM 32.49% 1-Year Est. Return
DIM
Delta Investment Management San Francisco, California $559M AUM 19.86% 1-Year Est. Return
NCA
Newbrook Capital Advisors New York $560M AUM 62.9% 1-Year Est. Return
CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.32% 1-Year Est. Return

Moody Aldrich Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Moody Aldrich Partners held 205 positions worth $712M, up 2.6% from $693M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Moody Aldrich Partners's Q2 2021 filing shows 25 new, 23 increased, 98 reduced and 34 closed positions. Its largest new stake was PubMatic: 349,715 shares worth $13.7M. The largest sale was Stifel, an estimated $19.7M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

  • Moody Aldrich Partners's largest Q2 2021 buy was PubMatic: 349,715 shares worth $13.7M.
  • Moody Aldrich Partners added most to LHC Group LLC in Q2 2021, an estimated $7.9M increase.
  • Moody Aldrich Partners's biggest Q2 2021 reduction was Stifel, cutting an estimated $19.7M.
  • Moody Aldrich Partners fully exited Louisiana-Pacific in Q2 2021, selling an estimated $13.7M.
  • Moody Aldrich Partners's ten largest holdings make up 20% of its $712M portfolio in Q2 2021.
  • Moody Aldrich Partners opened 25 new positions and closed 34 in Q2 2021.
  • Moody Aldrich Partners's portfolio value rose 2.6% quarter-over-quarter to $712M.

Based on Moody Aldrich Partners's 13F filing for Q2 2021, filed 4 Aug 2021.